Henning Nielsen

Prof. Dr. Henning Nielsen


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
PSPETER SCHOUSBOE
PETER SCHOUSBOE
BUBülent Uslu
Bülent Uslu
ASAmalie Schousboe
Amalie Schousboe
LNLars Nebrich
Lars Nebrich
LWLothar Wiese
Lothar Wiese
HNHenning Nielsen
Henning Nielsen
Background/Objectives: Critical lung infection affects alveolar cells and probably also their ability to perform surfactant procedures, but bedside tools for monitoring lung surfactants are lacking. In this descriptive exploratory study, we aimed to evaluate lung surfactant levels in bronchial aspirate (BA) from patients admitted to the intensive care unit due to severe respiratory failure. Methods: Bronchial aspirates were collected from nine patients (median age: 72 years, range: 52–85) who required orotracheal intubation. Samples were obtained within 24 h of mechanical ventilation initiation (T1), after three days on a ventilator (T2), and on day seven (T3) for four patients. The concentration of dipalmitoylphosphatidylcholine (DPPC), a key surfactant component, was assessed in the lamellar body precipitate. Results: Across the nine patients at T1, the DPPC level was 12 µM (range: 3–20 µM). By T2, the DPPC level declined to 8 µM (range: 2–22 µM), with a statistically significant decrease from T1 (p = 0.0039). At T3, the DPPC level in four patients ranged from 2 to 5 µM, though the difference from T2 was not statistically significant. A surfactant biomarker would assist clinical decision-making when dealing with patients in severe respiratory failure where exogenous surfactant therapy may be considered. Conclusions: DPPC levels obtained from bronchial aspirate can be measured in patients with severe respiratory failure and may serve as a useful biomarker for lung surfactant status, which suggests the potential for bedside assessment in clinical practice with a dedicated test device.

1 August 2025
Verified
Book Chapter
Open access
PDF file
HNHenning Nielsen
Henning Nielsen
Since Cushing described heart rate and blood pressure as the variables regularly recorded during surgery, the advancement of devices to record beat-to-beat changes in cardiac stroke volume has provided additional opportunities for perioperative monitoring. While such monitoring focuses on central parameters, as they are derived from the pressure curve, peripheral circulation has received little attention. Secondly, traditional monitoring does not reflect changes in cerebral blood flow, which needs to be considered in frail elderly patients who, due to conditions such as atherosclerosis, are vulnerable to hypotension secondary to impaired cerebral autoregulation. Here, near-infrared spectroscopy, and particularly cerebral oximetry, seem relevant to include in the toolbox for perioperative monitoring. For high-risk surgical patients, it is paramount to assess peripheral circulation during anesthesia. This chapter provides a narrative review of the relevance of the use of NIRS in the perioperative setting.